Reply to Ståhl et al. Comment on "Honndorf et al. Comparative Analytics and Pharmacodynamics of the Complex Protein-Free Botulinum Toxin Type A Formulations DaxibotulinumtoxinA, IncobotulinumtoxinA and RelabotulinumtoxinA. <i>Toxins</i> 2026, <i>18</i>, 142". [PDF]
Honndorf S +7 more
europepmc +1 more source
Endoscopic small bowel therapies for type 2 diabetes
Abstract Type 2 diabetes is a global epidemic despite current medical treatments. Many patients are not responsive to medications, and patients with obesity are hesitant about bariatric surgery. Studies investigating the metabolic effects of Roux‐en‐Y gastric bypass have increasingly demonstrated that the duodenum plays a key role in the ...
Roma Patel +4 more
wiley +1 more source
Early Onset of AbobotulinumtoxinA Effects in Post-Stroke Upper Limb Spasticity: A Prospective Observational Pilot Study. [PDF]
Marvulli R +4 more
europepmc +1 more source
Nutritional status and functions in children with cerebral palsy at different gestational ages
The nutritional status of cerebral palsy was significantly associated with their motor, eating and drinking ability, and their ability of daily living in the 28–32‐week and the ≥37‐week gestational age group, whereas in 33–36‐week group, correlation was only observed between the nutritional status and eating and drinking ability.
Hongmei Tang +14 more
wiley +1 more source
Anatomy-Based Botulinum Toxin Injection of the Posterior Belly of Digastric Muscle. [PDF]
Park HJ, Choi YJ.
europepmc +1 more source
Small Leucine‐Rich Proteoglycans in Cancer: Three Decades of Discovery
ABSTRACT Small leucine‐rich proteoglycans (SLRPs) are a well‐known family of extracellular matrix (ECM) molecules. They consist of five classes with 18 different protein cores originally recognized as having a physically supportive component to the extracellular structure and tissue integrity.
Gabriel J. Pascal +5 more
wiley +1 more source
Goal Attainment and Outcome Evaluation for Upper and Lower Limb Spasticity: A Real-Life Cohort Analysis in a Community-Based Outreach Service. [PDF]
Steed A +4 more
europepmc +1 more source
Botulinum toxin use in patients with neurological disorders: A U.S.‐based claims database analysis
Abstract Background and Objective Real‐world evidence describing long‐term persistency with botulinum toxin (BoNT) therapy is limited. We assessed treatment patterns and persistency with BoNT in clinical practice over 2 years. Design Retrospective, longitudinal, claims database analysis. Setting Medical claims data from the Merative MarketScan database
David M. Simpson +4 more
wiley +1 more source
Rome V Criteria for Adults: What's New and Why?
ABSTRACT The Rome V criteria, published in 2026, represent the culmination of a 7‐year effort to refine and improve the diagnostic framework for disorders of gut–brain interaction. The revision incorporates the latest consensus guidelines and emerging research while moving away from stigmatizing language and toward a more personalized, patient‐centered
Amanda Krause, Lin Chang
wiley +1 more source
Benefits of Incobotulinumtoxin A in Pain, Spasticity and Functionality-A 5 Years Review. [PDF]
Cruz A.
europepmc +1 more source

